|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,840.00 JPY | +3.97% |
|
+25.55% | -19.73% |
| 02-19 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 02-19 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
| Market Cap | 39.97B 246M 216M 199M 184M 350M 23.48B 355M 2.38B 925M 11.53B 925M 904M | P/E 2025 |
-103x | P/E 2026 | -56.3x |
|---|---|---|---|---|---|
| Enterprise Value | 36.07B 222M 195M 179M 166M 316M 21.19B 320M 2.15B 835M 10.4B 834M 816M | EV / Sales 2025 |
356x | EV / Sales 2026 | 255x |
| Free-Float |
73.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +3.97% | ||
| 1 week | +25.55% | ||
| Current month | +11.91% | ||
| 1 month | +12.69% | ||
| 3 months | -30.16% | ||
| 6 months | -22.19% | ||
| Current year | -19.73% |
| 1 week | 4,090 |  | 4,965 |
| 1 month | 3,610 | | 4,965 |
| Current year | 3,610 | | 12,400 |
| 1 year | 3,610 | | 12,400 |
| 3 years | 1,443 | | 12,400 |
| 5 years | 1,287 | | 12,400 |
| 10 years | 1,287 | | 12,400 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2020-05-31 | |
Yoshiki Sawa
CTO | Chief Tech/Sci/R&D Officer | 71 | 2021-07-31 |
| Investor Relations Contact | 44 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2024-05-31 | |
| Director/Board Member | 67 | 2020-07-31 | |
Tadashi Samejima
BRD | Director/Board Member | 66 | 2022-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-02-17 | Others | Chief Technology Officer | 24,000 | 0.2989% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.97% | +25.55% | -15.09% | +118.02% | 238M | |
| -0.68% | +2.85% | +20.76% | -7.81% | 66.56B | |
| -1.97% | -1.59% | +50.62% | +218.16% | 56.51B | |
| -1.13% | +40.50% | +40.50% | +40.50% | 42.98B | |
| +1.99% | +8.15% | -48.83% | -54.69% | 40.46B | |
| -3.54% | -3.77% | +60.19% | -26.85% | 31.91B | |
| +2.56% | +17.36% | +173.58% | -30.85% | 31.65B | |
| -1.06% | +0.84% | +71.87% | +83.93% | 23.35B | |
| +3.08% | +20.43% | +4.99% | +186.85% | 19.46B | |
| +0.21% | +2.96% | +66.67% | +129.01% | 17.18B | |
| Average | +0.16% | +10.25% | +42.53% | +65.63% | 33.03B | |
| Weighted average by Cap. | -0.60% | +7.70% | +43.41% | +52.51% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 175M 1.08M 944K 870K 807K 1.53M 103M 1.55M 10.41M 4.05M 50.47M 4.05M 3.96M | 212M 1.31M 1.14M 1.05M 978K 1.86M 125M 1.88M 12.61M 4.91M 61.15M 4.9M 4.8M |
| Net income | -644M -3.97M -3.47M -3.2M -2.97M -5.64M -378M -5.72M -38.31M -14.91M -186M -14.9M -14.57M | -1.02B -6.3M -5.51M -5.08M -4.71M -8.95M -601M -9.07M -60.79M -23.66M -295M -23.64M -23.12M |
| Net Debt | -4.79B -29.52M -25.86M -23.82M -22.11M -41.98M -2.82B -42.55M -285M -111M -1.38B -111M -108M | -3.9B -24.02M -21.03M -19.37M -17.98M -34.15M -2.29B -34.61M -232M -90.26M -1.12B -90.2M -88.22M |
Employees
51
Sector
Pharmaceuticals
Calendar
08-12 -
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | JP¥4,840.00 | +3.97% | 216,800 |
| 26-07-03 | JP¥4,655.00 | +6.16% | 155,900 |
| 26-07-02 | JP¥4,385.00 | +2.57% | 127,200 |
| 26-07-01 | JP¥4,275.00 | -1.16% | 85,100 |
| 26-06-30 | JP¥4,325.00 | -0.57% | 165,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4894 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
